Merck (NYSE:MRK) reported positive Phase 3 results for tulisokibart, an anti-TL1A monoclonal antibody in moderate-to-severe ...

Researchers at Peter MacCallum Cancer Centre have developed a digital phenotype to assist with automatically identifying ...

Ulcerative colitis (UC) can cause unpredictable symptoms that make life difficult. And research suggests that people with an inflammatory bowel disease (IBD) like UC have a higher risk of suicide ...

News and commentary from the world of gastroenterology and hepatology ...

AbbVie today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of upadacitinib (RINVOQ®; 15 ...

Once regarded as a disease affecting people over the age of 50, colorectal cancer is now rising at an alarming rate among ...

The study, published in JAMA Network Open, found the relative risk for inflammatory bowel disease (IBD) was about 8% higher in kids whose mothers took prescription proton pump inhibitors (PPI) or H2 ...

Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...

A quiet layer of biology is beginning to change how health is understood, and it sits on the surface of nearly every cell in ...

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of children six years of age and older with ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal ...

A study in Gut found that red wine may be associated with a lower risk of inflammatory bowel disease (IBD). But drinking roughly two alcoholic beverages a day was linked with a 10% to 30% higher risk ...